Correlation Between Curative Effect and Concentration of Drugs in Cerebrospinal Fluid in Tuberculous Meningoencephalitis
-
摘要:
目的 探索腰大池置管后，1次与2次鞘内注射异烟肼脑脊液中药物浓度监测，并观察浓度与疗效的相关性。 方法 按入组条件，收集90例结核性脑膜炎患者，随机分为3组，每组30例，分别为对照组、鞘内注射A1组和A2组；鞘内注射组均行腰大池置管术。通过观察2个鞘内注射组在0 h、6 h、12 h脑脊液中异烟肼浓度，比较1次与2次鞘内注射异烟肼脑脊液中药物浓度，并对比2组的疗效。 结果 对照组脑脊液中药物浓度在0 h处于较低的水平；鞘内注射的2组6 h后脑脊液药物浓度均高于对照组，但A2组脑脊液异烟肼浓度均比A1组高，差异有统计学意义（P < 0.05）。治疗2周后，A2有效率（90.0%）明显大于A1组（66.7%）。 结论 鞘内注射异烟肼比仅外周抗结核治疗结核性脑膜炎，疗效显著。同时2次鞘注比1次鞘注更能使异烟肼在脑脊液中维持较长时间的有效浓度，起到持续杀菌作用。也为不同严重程度的患者制定个性化治疗方案提供一定的依据。 Abstract:Objectives To explore the drug concentration in cerebrospinal fluid of isoniazid by one and two intrathecal injections after lumbar cisterna catheterization, and to analyze the correlation between concentration and curative effect. Methods Based on the inclusion criteria, 90 patients with tuberculous meningitis were selected and randomly divided into 3 groups with 30 patients in each group, including control group, intrathecal injection A1 group and A2 group, respectively. The 2 intrathecal injection groups received lumbar cistern catheterization. By observing the concentration of isoniazid in the cerebrospinal fluid of the two intrathecal injection groups at 0 h, 6 h and 12 h, the concentration of isoniazid in the cerebrospinal fluid of the one and two intrathecal injections was compared, and the efficacy of the two groups was compared. Result In the control group, the drug concentration in cerebrospinal fluid was lower at 0 h. After 6 h of intrathecal injection, the concentration of isoniazid in cerebrospinal fluid of group A2 was higher than that of group A1, the difference was statistically significant （P < 0.05）. After 2 weeks of treatment, the effective rate of A2 （90.0%） was significantly higher than that of A1 group （66.7%）. Conclusion Intrathecal injection of isoniazid is more effective than peripheral anti-tuberculosis treatment of tuberculous meningitis. Two intrathecal injections in one day can maintain the effective concentration of isoniazid in cerebrospinal fluid for a longer time than one intrathecal injection. It also provides a foundation for developing personalized treatment plan for patients of varying severity. -
Key words:
- Tuberculous meningitis /
- Isoniazid /
- Intrathecal injection /
- Drug concentration
-
表 1 0 h各鞘内注射组与对照组脑脊液异烟肼药物浓度检测值[（
$\bar x \pm s $ ）μg/L]Table 1. The concentration of isoniazid in cerebrospinal fluid of each intrathecal injection group and control group at 0 h [（
$\bar x \pm s $ ）μg/L]分组 0 h 对照组 1.31 ± 0.59 A1 2.01 ± 0.94* A2 2.61 ± 1.12* F 9.782 P 0.000 *P< 0.05。 
下载: 导出CSV
表 2 2个鞘内注射组6 h、12 h脑脊液药异烟肼物浓度检测值比较[（
$\bar x \pm s $ ）μg/L]Table 2. Comparison of isoniazid concentration detected in cerebrospinal fluid at 6 h and 12 h between the two intrathecal injection groups [（
$\bar x \pm s $ ）μg/L]分组 6 h 12 h A1 32.76 ± 29.17 5.16 ± 2.91 A2 375.81 ± 224.31* 43.88 ± 36.29* t −6.080 −4.258 P 0.000 0.001 *P< 0.05。
下载: 导出CSV
表 3 各组治疗2周后疗效对比[n（%）]
Table 3. Comparison of curative effect of each group after 2 weeks of treatment [n（%）]
分组 有效 无效 合计（n) 对照组 12（40.0 ） 18（60.0 ） 30 A1 20（66.7 ）* 10（33.3 ）* 30 A2 27（90.0 ）*# 3（10.0 ）*# 30 合计 38（62.2 ） 22（37.8 ） 90 与对照组比较，*P< 0.05；与A1组比较，#P < 0.05。
下载: 导出CSV
-
[1] Jain S K,Tobin D M,Tucker E W,et al. Tuberculous meningitis:A roadmap for advancing basic and translational research[J]. Nature Immunology,2018,19(6):521-525. doi: 10.1038/s41590-018-0119-x [2] Mirjam C. Effect of procalcitionin-guded treatment on antibiotic use and outcome in lower respiratory tract infections:Cluster-randomised,single-blinded intervention trail[J]. Lancet,2004,363(9409):600. doi: 10.1016/S0140-6736(04)15591-8 [3] 刘其会,张文宏. 抗结核药物药动学/药效学研究进展[J]. 中国感染与化疗杂志,2016,16(5):662-666. [4] 张亮,冯枭,林霏申,等. 异烟肼血药浓度的影响因素分析[J]. 药学与临床研究,2018,26(6):413-416. [5] 周晛,孙峰,张文宏. 结核性脑膜炎治疗新策略的研究进展[J]. 中华临床感染病杂志,2016,9(5):477-480. doi: 10.3760/cma.j.issn.1674-2397.2016.05.023 [6] 马俊. 测定血浆及脑脊液中异烟肼浓度调整个体化给药方案[C]. 中国药理学会治疗药物监测研究专业委员会. 第二届全国治疗药物监测学术年会会议指南. 中国药理学会治疗药物监测研究专业委员会: 中国药理学会, 2012: 36 [7] 马玙, 朱莉贞, 潘毓萱. 结核病[M]. 北京: 人民卫生出版社, 2006: 254-262. [8] Thwaites G,Fisher M,Hemingway C,et al. British infection society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children[J]. J Infect,2009,59(3):167-187. doi: 10.1016/j.jinf.2009.06.011 [9] 中华医学会结核病学分会,颅内结核影像学分型专家共识编写组. 颅内结核影像学分型专家共识[J]. 中华结核与呼吸杂志,2015,38(11):805-809. [10] 方伟军,宋敏,韩远远,等. 颅内结核MRI特征及抗结核化疗过程中MRI表现分析[J]. 新发传染病电子杂志,2020,5(2):107-112. doi: 10.3877/j.issn.2096-2738.2020.02.011 [11] 郎美琦,蒋利,黄佳盛. 抗结核病药物治疗综述[J]. 临床肺科杂志,2010,15(8):1153-1154. doi: 10.3969/j.issn.1009-6663.2010.08.049 [12] 宋艳华,高孟秋,李琦. 结核分枝杆菌对异烟肼和乙硫异烟胺/丙硫异烟胺耐药机制的研究进展[J]. 中国医刊,2020,55(6):604-608. doi: 10.3969/j.issn.1008-1070.2020.06.010 [13] Jung J A,Kim T E,Lee H,et al. Aproposal for an individualized pharmacogenetic-guided isoniazid dosage regimen for patients with tuberculosis[J]. Drug Des Devel Ther,2015,15(9):5433-5438. [14] 周俊,刘元,吕小会,等. 异烟肼、利福平和吡嗪酰胺血药浓度的稳定性及差异分析[J]. 中国药物警戒,2019,16(11):678-682,687. [15] 刘诚诚,金海霞,徐建,等. 结核病患者N一乙酰基转移酶2基因型与异烟肼血药浓度关系的研究[J]. 中国防痨杂志,2013,35(3):179-182. [16] 中华医学会结核病学分会. 抗结核新药贝达喹啉临床应用专家共识[J]. 中华结核和呼吸杂志,2018,41(6):461-466. doi: 10.3760/cma.j.issn.1001-0939.2018.06.005 [17] 刘会民,张洁,张永进. 我院异烟肼血药浓度监测结果分析[J]. 天津药学,2011,22(6):27-28. doi: 10.3969/j.issn.1006-5687.2011.06.011 [18] 西娜,赵冠人,陈明,等. 高效液相色谱-串联质谱法测定人脑脊液中一线抗结核药浓度[J]. 中国医院用药评价与分析,2020,20(1):69-72. [19] 魏香兰,方如塘,师延峰,等. 抗结核药物的血药浓度监测结果分析[J]. 中国医院药学杂志,2015,35(21):1918-1921. [20] 孟繁荣,刘炜雯,吴玲,等. 异烟肼药物浓度及作用时间对结核分枝杆菌生长状态的影响[J]. 国际医药卫生导报,2014,20(24):3719-3721. doi: 10.3760/cma.j.issn.1007-1245.2014.24.016 -
